HEALTHSTREAM INC

For the period ended Dec 31, 2025. Filed Feb 27, 2026.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Feb 27, 2026

HSTM$28.85-0.1%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Signatures

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on this 26th day of February 2026.

HEALTHSTREAM, INC.

By: /s/ ROBERT A. FRIST, JR.

Robert A. Frist, Jr.

Chief Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed by the following persons on behalf of the registrant and in the capacities and on the dates indicated:

Thompson S. Dent
Signature	Title(s)	Date
/s/ ROBERT A. FRIST, JR.	Chief Executive Officer and	February 26, 2026
Robert A. Frist, Jr.	Chairman (Principal Executive Officer)
/s/ SCOTT A. ROBERTS	Chief Financial Officer and Senior Vice President	February 26, 2026
Scott A. Roberts	(Principal Financial and Accounting Officer)
/s/ THOMPSON S. DENT	Director	February 26, 2026
/s/ FRANK E. GORDON	Director	February 26, 2026
Frank E. Gordon
/s/ TERRY ALLISON RAPPUHN	Director	February 26, 2026
Terry Allison Rappuhn
/s/ JEFFREY L. MCLAREN	Director	February 26, 2026
Jeffrey L. McLaren
/s/ LINDA REBROVICK	Director	February 26, 2026
Linda Rebrovick
/s/ A. ALEX JAHANGIR	Director	February 26, 2026
A. Alex Jahangir
/s/ CHARLES E. BEARD, JR.	Director	February 26, 2026
Charles E. Beard, Jr.
/s/ DEBORAH TAYLOR TATE	Director	February 26, 2026
Deborah Taylor Tate

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.